New Study for Volunteers
Name of Study: The COVID-19/Flu Study
Summary of Study: This study is testing a potential new booster vaccine to protect against COVID-19. The vaccine will be given with a seasonal flu vaccine.
Inclusion Criteria
· Have already received at least 3 doses of mRNA COVID-19 vaccines (Pfizer or Moderna)
· Other criteria apply
Exclusion Criteria
· Tested positive to COVID-19 in the last 5 months
· Received a COVID-19 vaccine in the last 5 months
· Other criteria apply
Age: 18 years and older
Start Date: March 2024
Study Medication : Vaccine administered at 2 separate study visits, 1 month apart
Length of Study: 4 - 5 clinic visits over 6 months
Remuneration: Enrolled participants will be reimbursed for their time and for reasonable travel expenses. There is no cost to participants for study visits or study medications.
Click Here to find out more: Study Details | Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults | ClinicalTrials.gov
To register - please complete details below or email us at info@clinitrials.com.au